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Summary: We studied the in vitro effect of dipyrone on the determination of free triiodothyronine (free T3),
cortisol, progesterone, estradiol, carcinoembryonic antigen, human chorionic gonadotropin and α-fetoprotein mea-
sured with an immunoenzyme assay based on enhanced luminescence that uses peroxidase as label. We found
significant interference from dipyrone (p < 0.01) in the determination of all the analytes mentioned: for progester-
one and estradiol the interference was present at high doses of dipyrone; for free T3 and cortisol the minimum
dipyrone concentration producing interference was 712 μηιοΐ/ΐ and for carcinoembryonic antigen, human chorionic
gonadotropin and a-fetoprotein 44 μπιοΐ/ΐ. Dipyrone has an analytically and statistically significant interference
effect on the determination of the mentioned analytes.
Introduction
Dipyrone (noramidopyrine methanesulfonate), one of
the oldest synthetic pyrazolone derivatives, is an effec-
tive analgesic, antipyretic and anti-inflammatory drug
(1). Due to its high solubility, it can be administered
intravenously. Some of the secondary effects dipyrone
can produce are: allergic reactions, skin eruptions and
central nervous system alterations. In spite of its infre-
quent undesirable effect (agranulocytosis) (2), dipyrone
is one of the most widely used analgesic drugs in Spain.
It is mainly administered for the treatment of acute
postsurgical or postraumatic pain and renal colic pain
(3).
We have demonstrated the negative interference by di-
pyrone, in vitro and in vivo, in the determination of sev-
eral biochemical analytes (4, 5). The common feature of
the majority of these methods was a final reaction in-
volving the enzyme peroxidase1).
Peroxidases consist of a wide group of enzymes with
different functions. The longest and the best studied is
Peroxidase: EC 1.11.1.7
horseradish peroxidase (6) which is used in many
immunoassay techniques.
The objective of this work is to examine the in vitro
effect of dipyrone on several analytes measured by
immunoassay techniques using peroxidase as a label.
Materials and Methods
Instrumentat ion
We measured the following analytes in serum: free T3, cortisol,
progesterone, estradiol, carcinoembryonic antigen, human chor-
ionic gonadotropin and α-fetoprotein. For all the measurements we
used Amerlite reagents on the Amerlite Analyzer (Kodak Clinical
Diagnostics Ltd, Amersham, UK).
Procedures
The determination of free T3, cortisol, progesterone and estradiol
is based on a competitive technique using enhanced luminescence.
The method uses coated wells as solid phase and horseradish per-
oxidase as label. After removing the unbound fraction, the horse-
radish peroxidase activity of the bound conjugate is measured by
an enhanced luminescence reaction obtained with the addition of
the signal reagent that contains hydrogen peroxide as substrate,
luminol as luminogen and a compound that enhances the intensity
of light produced and prolongs its emission (the substituted phenol
p-iodophenol). The amount of conjugate bound is inversely propor-
tional to the concentration of analyte present in the sample.
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The Amerlite carcinoembryonic antigen, human chorionic gonado-
tropin and α-fetoprotein assays are based on a non-competitive de-
sign involving a polyclonal antibody coated on to the wells and a
horseradish peroxidase-conjugated monoclonal antibody. The
horseradish peroxidase activity of the bound conjugate is measured
by the enhanced luminescence reaction and the amount of conju-
gate bound is directly proportional to the concentration of analyte
present in the sample.
Study in vitro
The possible interference of dipyrone on the different analytical
methods was studied following the recommendations of the Socie-
dad Espanola de Quimica Clinica (7) and the guidelines of the
National Committee for Clinical Laboratory Standards (8) for the
detection and quantification of in vitro drug interference. We pre-
pared a homogenous pool of fresh serum samples and we added
dipyrone (Sigma, St. Louis, MO; cat. no. D-8890) to one half of
this pool to a final concentration of 10 g/1 (28460 μπιοΐ/ΐ), ten-fold
higher than the expected maximum concentration obtained after a
standard dose of dipyrone, as suggested by Melvin R. Click (9);
the rest of the pool of serum containing different concentrations of
the analytes studied was free from the interfered. Both pools were
analyzed 15 times for each analyte. The outliers were eliminated
by Dixon's criteria (10, 11). We tested the normality and homosce-
dasticity of the data by using the Agostino normality and Snedecor
F tests, respectively, so that we could compare the means of both
groups with results from the Mann-Whitney U test. If the differ-
ences between means were significant (p < 0.01), the drug was
considered to be an interferent.
To quantify the interference, we diluted the pooled sera containing
10 g/1 (28460 μηιοΐ/ΐ) of dipyrone with serum from the drug-free
pool to obtain a series of samples containing dipyrone at 14230,
7115, 2846, 1523, 712, 356, 178, 89 and 44 μπιοΐ/ΐ. Five replicates
of each sample were analyzed. Differences of mean concentrations
of the analytes between the drug-free pool and the samples contain-
ing the interferent were evaluated for each method by using the
Mann-Mutney U test.
Results
Table 1 shows the original concentrations determined for
the serum samples we used in these studies and the min-
imum concentration of dipyrone that produced any inter-
ference with measurements of the different analytes.
Tab. 1 Original concentrations of the quantities and Minimum





































The results obtained from the quantification of the inter-
ference are represented by the interferographs, an easy
format to present interference data obtained in the labo-
ratory (9): the average assay value for each specimen
was calculated as fraction of the original concentration
(without interferent); by plotting, fhese fractions vs the
concentration of potential interferant added, we drew
these graphs (figs. 1-7).
Discussion
The main goal of an interference study is to determine
if interference is present, and if so, to distinguish be-
tween a statistically significant effect and clinically sig-
nificant interference. Lastly, the establishment of the
type of interference offers a clearer understanding of its
chemical nature.
The results from the Mann-Whitney U test obtained in
the studies in vitro were consistent with the presence of
significant interference (p < 0.01) by dipyrone for all
the analytes listed in tab. 1. It is important to note that
the interference produced by dipyrone on the determina-
tion of progesterone and estradiol (at concentrations
shown in table 1) is present only at dipyrone concentra-
tions higher than the maximum concentration obtained
after a standard dipyrone dose. For the rest of the quanti-
ties studied, the minimum dipyrone concentrations pro-
ducing interference ranged from 44 to 712 μιηοΐ/ΐ. This
range includes dipyrone concentrations that can be ob-
served in a patient after a standard dipyrone dose (1).
The interference is positive or negative depending on
the type of technology studied: positive interference in
competitive methods and negative interference in non-
competitive ones. Dipyrone therefore interferes posi-
tively with the determination of free T3, cortisol, estra-
diol and progesterone and negatively on the measure-
ment of carcinoembryonic antigen, human chorionic go-
nadotropin and a-fetoprotein.
From this data we demonstrate that dipyrone has an ana-
lytically and statistically significant in vitro interference
on the concentration of several analytes determined by
peroxidase labelled immunoassays. This interference is
produced through a direct and specific inhibitory effect
on the enzyme label since dipyrone can cause a varying
loss of activity in peroxidase (12). We conclude that
clinical laboratory data obtained by these methods in pa-
tients taking dipyrone should be carefully evaluated.
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Fig. l Interferograph for free T*
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Fig. 2 Interferograph for cortisol
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Dipyrone [pmol/l]
Fig. 6 Interferograph for human chorionic gonadotropin
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Fig. 3 Interferograph for progesterone
Dipyrone [μηηοΙ/Ι]










Fig. 4 Interferograph for estradiol
Figs. 1-7
The starlets indicate significant (p < 0.01) interference
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